Abstract. The importance of metabolic syndrome (MetSy) 
Introduction


Metabolic syndrome (MetSy) represents a group of cardiovascular risk factors, such as obesity, hypertension, insulin resistance and dyslipidemia. The importance of MetSy lies in the fact that its components are proven risk factors for early blood vessel atherosclerosis and thrombosis [1] , and individuals with MetSy have a three times greater risk to develop cardiovascular complications compared to those who do not have the syndrome [1, 2] . Further, adult individuals with MetSy are exposed to a five-time greater risk of type 2 diabetes mellitus [3] . (NECP/ATP III), and European Group for the Study of Insulin Resistance (EGIR). The definition by the expert team of the Third Panel of the National Cholesterol Education Program is based on the presence of three of the following five criteria: abdominal obesity, hypertriglyceridemia, low HDL cholesterol, elevated blood pressure and hyperglycemia [4] . The prevalence of MetSy varies considerably depending on the criteria used to diagnose the condition.
In patients without manifest cardiovascular disease, the thickness of the intimal medial complex (IMC) and ankle-brachial (pressure) index (ABI) represent noninvasive surrogate markers of atherosclerosis associated with an increased risk for cardiovascular morbidity and mortality [5] . The literature data suggest a clear association between cardiovascular risk factors and intimal medial thickness, as well as between intimal medial thickness and presence of clinical manifestations of coronary disease [68] . It has been shown that intimal medial thickness of the carotid arteries directly correlates with the involvement of cerebral, peripheral, and coronary vascular bed by the process of atherosclerosis [6] .
Aim of the paper
Our aim in this paper was to establish the prevalence of metabolic syndrome in patients with arterial hypertension (AH), as well as its impact on asymptomatic carotid atherosclerosis.
Methods
The study involved 391 examinees divided into two groups. The study group consisted of the patients with arterial hypertension (n=342; average age, 66.56 ± 09.52; with 51% of women). In all the patients the presence of cardiovascular risk factors was established, cardiovascular risk score was determined (SCORE risk), laboratory analyses were performed, as well as anthropomentric measurements and color Doppler sonography of the great blood vessels of the neck.
Analysis of the risk factors
Based on the patient history and relevant medical records, the presence of both modifiable and unmodifiable risk factors for cardiovascular diseases was analyzed: AH, hyperlipidemia, smoking, diabetes, obesity, gender and age. Hypertension was defined based on the anamnestic data, medical records, measured systolic blood pressure values of over 140 mmHg and diastolic blood pressure of over 90 mmHg, or use of antihypertensive medications. The examinees with total cholesterol values of over 5.0 mmol/L and/or triglycerides of over 1.7 mmol/L who were taking hypolipemic therapy were considered to be hyperlipidemic. The presence of diabetes was confirmed based on patient history information, available medical records, measured fasting glucose values of over 5.6 mmol/L, or use of oral hypoglycemic medication or insulin therapy. The examinees with body mass index (BMI) ≥30 kg/m² were considered to be obese. An interactive electronic version of the SCORE risk charts from the European Society of Cardiology guidelines on CVD prevention (prepared by the Third Joint Working Group of the European Association of Preventive Cardiology -Heartscore) was used to assess the risk of fatal cardiovascular events in our examinees.
Metabolic syndrome was diagnosed in accordance with the NECP/ATP III metabolic syndrome diagnostic criteria (The National Cholesterol Education Program, Adult Treatment Panel).
Laboratory analyses
General laboratory analyses were done in all the examinees. Values of the following laboratory parameters were measured: total cholesterol, HDL and LDL cholesterol fractions, triglycerides, creatinine, serum uric acid (employing standard laboratory methodology and using a Humastar 600 biochemical analyzer). Creatinine clearance was determined using the Cockcroft-Gault formula.
Anthropometric measurements
Anthropometric measurements involving body weight, body height, waist and hip circumference measurements were done in all examinees in order to get an insight into their nutritional status. The measurements were performed with light clothes and without any footwear. Body mass index (BMI) was determined using the following formula: body weight in kg/body height in m 2 .
Color Doppler sonography (CDS) of the great blood vessels in the neck
Color Doppler sonography of the great blood vessels in neck was done in all our examinees using the ultrasound scanner system EsaoteBiomedica, My Lab60 Xvision, with a multifrequency linear probe of 413 MHz. Intraluminal lesions were determined using B-mode imaging and defined as changes in the form of IMC thickening and appearance of plaques as focal intimal thickenings. IMC thickness was measured in the posterior wall of the common carotid artery 2 cm away from the top of the bifurcation, in the region without any focal changes. Longitudinal images of the common carotid artery and its branches (internal and external carotid artery) were analyzed bilaterally, determining the diameter of stenosis and analyzing plaque properties. Interpretations were based on the combination of B-mode, i.e. real-time tissue imaging, and Doppler spectral analysis.
Statistical data processing
The following statistical parameters were presented in the description: arithmetic mean (Xsr), standard deviation (SD), absolute value and percentage (%) of attributive properties. Comparison of the mean values of numerical properties between the two groups of examinees was done using the Student's t-test. Linear regression analysis (by Spearman) was used to evaluate the association of the factors of interest. The factors demonstrating a considerable impact on dependent variables in univariate analysis were included in multivariate models as independent variables. Statistical data processing was done using the SPSS software, 17.0 version. In all the analyses, the assessment error of 0.05 or 5% was taken as the cut-off of statistical significance.
Results
The patients with hypertension were divided into two groups by the presence of MetSy. Metabolic syndrome was confirmed in 198 patients and these comprised group I, while 144 examinees were without MetSy and these comprised group II. There was no age difference between the examinees with and those without MetSy. Those with MetSy had a greater average number of risk factors for cardiovascular diseases (CVD), a higher CV risk score -SCORE, and higher body mass index (p<0.0001), and in this group of patients, diabetes, hyperlipidemia and obesity were more common (p <0. 0001), (Table 1) . Examinees from the group I (with MetSy) had higher values of fasting glucose in the serum, higher levels of triglycerides and uric acid (p<0.0001), and lower values of HDL cholesterol fraction (Table 2) . 
Analysis of color Doppler ultrasound of the great blood vessels in the neck
The thickness of the carotid IMC was significantly greater in the group with MetSy compared to those without the condition (p<0.0001), and 51% of examinees had IMC thickness of ≥0.90. Those with MetSy more commonly had one or more carotid plaques (p=0.03), a greater average number of plaques (p=0.01) and a higher percentage of stenosis (p=0.01) compared to group II examinees (Table 3) . Analyzing the carotid plaque characteristics, it was found that in the MetSy group plaques were most commonly fibrocalcified (29%), then fibrous (22%) and calcified (19%), and in the group without MetSy fibrous plaques were most prevalent (28%) ( Table 4) . 
Discussion
Disorders of lipid and glucose metabolism, obesity and AH are defined as risk factors for cardiovascular diseases, and these are at the same time the components of MetSy [1] . The prevalence of MetSy has been on the rise worldwide, but it is difficult to establish the prevalence more precisely due to different criteria used to define the condition. The INTERHEART study, performed in 52 countries throughout the world, demonstrated the prevalence of MetSy to be about 26% [9] . According to the data of the National Health and Examination Survey, the prevalence of MetSy in the United States of America changes with age; in men below 40 years of age it is 20%, and in women of the same age it is 16%, while the prevalence of the condition in individuals of either gender aged over 60 years even exceeds 50% [10] .
In our examinees with AH, the prevalence of MetSy was significantly higher compared to controls, as well as the average number of present MetSy components. Those with AH and MetSy had a greater average number of risk factors for cardiovascular diseases, a higher CV risk score -SCORE, higher BMI, and diabetes, hyperlipidemia and obesity were more common in these individuals (Table 1) .
In the PIUMA study in Umbria, Italy, 1.742 examinees without any manifest CV disease were prospectively observed for 10.5 years on the average; MetSy was established in 34% of them. Those with MetSy were older, and with longer history of AH and higher systolic blood pressure values. It was shown that MetSy was an independent predictor of future cardiovascular diseases in individuals of either gender with essential AH, and this prognostic effect of MetSy was not dependent on the traditional cardiovascular factors of risk, including left ventricular hypertrophy and ambulatory blood pressure measurement [11] . In the PIUMA study, the prevalence of diabetes was 14% [11] , while in our examinees with MetSy the prevalence of diabetes was 30%, while in those without MetSy it was 2.1% (Table 1) . The study by Marjani et al. showed a rather high prevalence of MetSy in patients with type 2 diabetes, with the percentage being higher in women (53.27%) than in men (48.71%) [12] .
The prevalence of hyperlipidemia in our examinees was rather high -81.2% in the first, and 63% in the second group. Laboratory analyses showed higher values of fasting glucose in the serum in patients with MetSy, higher triglyceride and uric acid levels, and lower values of HDL cholesterol fraction. There were no differences in the values of total and LDL cholesterol, probably due to the fact that the examinees with previously diagnosed hypercholesterolemia were treated with hypolipemic agents and/or employed non-pharmacological treatment measures. In individuals with MetSy, the so called atherogenic dyslipidemia predominates, characterized by increased triglycerides and decreased HDL cholesterol, while LDL may be normal or only slightly elevated. Triglycerides play a significant role in the processes of atherogenesis and thrombogenesis; in a metaanalysis involving 101 prospective studies with 302.430 examinees, it has been confirmed that elevated triglycerides are an important factor associated with the development of coronary heart disease [13] .
The studies undertaken in Greece and the USA have shown that the prevalence of metabolic syndrome is similar in both genders [14] . On the other hand, there have been studies indicating a higher prevalence of MetSy in women or in men [15] . In our study, women more commonly had MetSy (59.6%). Deibert et al. demonstrated a prevalence of MetSy in postmenopausal women of 36.1% [16] . Furthermore, there have been studies suggesting that the differences in MetSy prevalence may be influenced by genetic factors and ethnicity as well [17] .
Cardiovascular risk in individuals with MetSy is the product of different combinations of the components of the syndrome, which are not at all uniform. Each of the components is an independent risk factor for CVD and their synergistic action additionally increases the risk. Cardiovascular mortality is increased with an increasing number of MetSy components [18] . The results of multivariate regression analysis in our study singled out the number of MetSy components as one of the most important factors associated with atherosclerosis of the carotid arteries.
Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) observed for 11.6 years on the average 1.209 seemingly healthy men aged 42 to 60 years, where it was shown that CVD fatalities were 2.94.2 times more common in the presence of MetSy [19] . Among the patients of more advanced age (7079 years), the presence of MetSy was associated with a higher prevalence of coronary events, myocardial infarction, heart failure and hospitalizations regardless of the cause in the Health, Aging and Body Composition Study (HealthABC study) [20] . In the Medicine, Angioplasty or Surgery Study (MASS II), the patients with stable coronary disease were followed up for two years; those with MetSy had poorer CV outcomes and 2.5 times higher mortality independent of the factors of age, gender, smoking, LDL cholesterol and number of involved coronary blood vessels. The mortality of patients with MetSy was 10.6% after two years, compared to 5.2% in those without MetSy [21] .
The current European guidelines for CVD prevention in clinical practice, similarly to their predecessors, recommend the use of the SCORE system to assess the risk in asymptomatic patients since it has been based on a large representative European cohort [22] . In all the patients involved in our study SCORE was determined, and the obtained results demonstrated statistically significantly higher SCORE values in those with AH and MetSy ( Table 1) . The results such as these could be in part expected, since the SCORE system was based on the presence or absence of some of the MetSy components. Non-invasive imaging methods are able to identify asymptomatic atherosclerosis in various arterial areas and therefore supplement the assessment of risk. A special significance of these approaches lies in the detection of changes in their subclinical phase in individuals at high risk for the development of cardiovascular diseases, so that the measures of prevention and appropriate treatments could be timely introduced.
IMC thickness in the common carotid arteries represents a solid indicator of early atherosclerosis [23] , and a number of studies, including the Multi-Ethnic Study of Atherosclerosis (MESA) in asymptomatic patients, have shown that the IMC thickness exceeding 75 percentiles for age, gender and race is associated with the risk for myocardial infarction, stroke and cardiovascular mortality independently of other conventional risk factors [24] . The association of MetSy with subclinical atherosclerosis was the subject of a number of studies employing non-invasive imaging techniques. In the study by Holewijn et al., involving 1.517 individuals with MetSy aged 50 to 70 years, a significant association was found between asymptomatic atherosclerosis and MetSy, regardless of the employed imaging method [25] .
IMC thickness of the carotid arteries in our examinees was significantly greater in the group with MetSy compared to those without MetSy (Table 3) , where increased IMC thickness (≥ 0.90) was found in 51% of examinees with MetSy. Those with MetSy more commonly had one or more carotid plaques, a greater average number of plaques and percentage of stenosis (Table 3). Similar results were published by Olijhoek et al. in the Netherlands, examining the association of MetSy with changes in the coronary, cerebral and peripheral arteries. The prevalence of MetSy in that study was 45%; their patients had greater IMC thickness, a lower anklebrachial index, and more prevalent microalbuminemia compared to those without MetSy. Furthermore, they demonstrated that with an increasing number of MetSy components, IMC thickness increased as well [26] .
In our analysis of the characteristics of carotid plaques, we found that in our examinees with MetSy plaques were most commonly fibrocalcified, then fibrous and lastly calcified, while in those without MetSy fibrous plaques predominated (Table 4) . However, it was interesting to note that lipid plaques were not present in any of the 342 patients with AH, with or without MetSy. The presence of soft lipid and fibrolipid plaques has been usually associated with the risk for neurological complications (transitory ischemic attacks, reversible ischemic deficits or cerebrovascular insults) due to an increased embolic potential of these plaques [27] . On the other hand, the presence of carotid plaques suggests that plaques in the coronary arteries may be present as well. The presence of less echo-lucent plaques in stable coronary patients has been able to predict acute coronary syndrome in the future, regardless of the presence of other factors of risk [28] . Khoury et al. have demonstrated that patients with multi-vessel coronary disease had a higher carotid plaque score compared to those with single-vessel coronary disease or normal coronary blood vessels [29] . Recent analyses have shown that the presence plaques in the carotid arteries has a greater predictive significance regarding future CV events, compared to IMC thickness [30] .
Conclusion
Arterial hypertension is commonly associated with metabolic disorders, especially with insulin resistance and MetSy. In our study, we demonstrated that in patients with AH the prevalence of MetSy was significantly higher than in healthy individuals. Patients with AH and MetSy had a greater average number of risk factors for cardiovascular diseases, higher score of CV risk -SCORE, higher body mass index, diabetes was more often present, as well as hyperlipidemia and obesity. The results indicated the presence of a significant association between MetSy and its components and atherosclerotic changes in the carotid arteries.
